These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Differential diagnosis of chronic inflammatory bowel diseases. Possibilities and limits of morphology]. von Herbay A; Otto HF Chirurg; 1992 Jan; 63(1):1-7. PubMed ID: 1547638 [No Abstract] [Full Text] [Related]
43. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Evans JM; McMahon AD; Murray FE; McDevitt DG; MacDonald TM Gut; 1997 May; 40(5):619-22. PubMed ID: 9203940 [TBL] [Abstract][Full Text] [Related]
44. TNF alpha secreting cells in normal and diseased human intestine. Breese E; MacDonald TT Adv Exp Med Biol; 1995; 371B():821-4. PubMed ID: 7502905 [No Abstract] [Full Text] [Related]
45. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease. Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030 [TBL] [Abstract][Full Text] [Related]
46. Factors associated with disease evolution in Greek patients with inflammatory bowel disease. Chatzicostas C; Roussomoustakaki M; Potamianos S; Paspatis G; Mouzas I; Romanos J; Mavrogeni H; Kouroumalis E BMC Gastroenterol; 2006 Jul; 6():21. PubMed ID: 16869971 [TBL] [Abstract][Full Text] [Related]
47. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa. Danelius M; Ost A; Lapidus AB Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988 [TBL] [Abstract][Full Text] [Related]
48. [Morphological and immunohistochemical characteristic of oral mucosa in patients with inflammatory bowel disease]. Kvetnoĭ IM; Robakidze NS; Kostiuchek IN; Shchukina OB; Proshchaev KI Adv Gerontol; 2010; 23(3):371-4. PubMed ID: 21137207 [TBL] [Abstract][Full Text] [Related]
49. [Detection of increased permeability of the intestinal mucosa in chronic inflammatory bowel diseases]. Karbach U Z Gastroenterol Verh; 1989 Jul; 24():40-4. PubMed ID: 2474980 [No Abstract] [Full Text] [Related]
50. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Walsh A; Palmer R; Travis S Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528 [TBL] [Abstract][Full Text] [Related]
51. Adverse effects of nonsteroidal anti-inflammatory drugs on the small and large bowel. Schneider AR; Benz C; Riemann JF Endoscopy; 1999 Nov; 31(9):761-7. PubMed ID: 10604623 [TBL] [Abstract][Full Text] [Related]
52. Numerical taxonomy and discriminant analysis applied to non-specific colitis. Jones JH; Lennard-Jones JE; Morson BC; Chapman M; Sackin MJ; Sneath PH; Spicer CC; Card WI Q J Med; 1973 Oct; 42(168):715-32. PubMed ID: 4606853 [No Abstract] [Full Text] [Related]
53. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation. Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773 [TBL] [Abstract][Full Text] [Related]